Research Article

Overexpression of GSE1 Related to Trastuzumab Resistance in Gastric Cancer Cells

Figure 3

Depletion of GSE1 decreased the trastuzumab resistance in trastuzumab-resistant gastric cancer cells. MKN45-HR and NCI-N87-HR cells were transfected with shGSE1 or shNC (designated as MKN45-HR shGSE1, MKN45-HR shNC, NCI-N87-HR shGSE1, and NCI-N87-HR shNC, respectively). (a) Protein levels of GSE1 were examined by western blotting. β-Actin was a negative control. (b) Cells were treated with 10 μg/ml trastuzumab for 6 days, and cell viabilities were detected by MTT assay. (c) 3-D matrigel cell culture assay was performed to evaluated cell 3-D growth with trastuzumab treatment for 6 days. . .
(a)
(b)
(c)